Disappearance of cryoproteins in the sera of a patient with SLE after treatment with blisibimod, a novel subcutaneous anti-B cell therapy.
Golmia, Andrea Pimentel Fonseca
Disappearance of cryoproteins in the sera of a patient with SLE after treatment with blisibimod, a novel subcutaneous anti-B cell therapy. [electronic resource] - Rheumatology (Oxford, England) May 2014 - 957-8 p. digital
Publication Type: Case Reports; Letter
1462-0332
10.1093/rheumatology/ket361 doi
B-Cell Activating Factor--drug effects
B-Lymphocytes--drug effects
Cell Proliferation--drug effects
Cryoglobulins--metabolism
Female
Humans
Injections, Subcutaneous
Lupus Erythematosus, Systemic--blood
Recombinant Fusion Proteins--administration & dosage
Treatment Outcome
Disappearance of cryoproteins in the sera of a patient with SLE after treatment with blisibimod, a novel subcutaneous anti-B cell therapy. [electronic resource] - Rheumatology (Oxford, England) May 2014 - 957-8 p. digital
Publication Type: Case Reports; Letter
1462-0332
10.1093/rheumatology/ket361 doi
B-Cell Activating Factor--drug effects
B-Lymphocytes--drug effects
Cell Proliferation--drug effects
Cryoglobulins--metabolism
Female
Humans
Injections, Subcutaneous
Lupus Erythematosus, Systemic--blood
Recombinant Fusion Proteins--administration & dosage
Treatment Outcome